Centre for Lifespan and Chronic Illness Research, University of Hertfordshire, Hatfield, UK.
Nephron Clin Pract. 2011;119(3):c205-13. doi: 10.1159/000329106. Epub 2011 Aug 11.
Patients with end-stage renal disease (ESRD) receiving haemodialysis are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate (PO(4)). Phosphate binders are an important treatment; however, non-adherence remains a significant issue. This study investigates whether patients' beliefs about medicines predict intentional non-adherence to phosphate binders.
This was a cross-sectional study of ESRD patients (n = 76). Non-adherence was measured in two ways: (1) the self-report Medication Adherence Questionnaire (MAQ) and (2) 3-month average level of serum phosphate. The Beliefs about Medicines questionnaire was used to assess general and specific beliefs towards phosphate medicines.
Eleven (14.5% of 76) patients reported being intentionally non-adherent to phosphate binders. Patients' beliefs that phosphate binders were less necessary were significantly associated with intentional self-reported non- adherence. Furthermore, patients with greater concerns about phosphate binders had higher serum phosphate levels.
Assessing patient beliefs about medicines is a reliable indicator of intentional non-adherence to treatment with phosphate binders. These findings may help in identifying ways in which adherence rates to phosphate binders can be improved.
接受血液透析的终末期肾病(ESRD)患者存在心血管疾病和与血清磷酸盐(PO(4))水平升高相关的骨病风险。磷酸盐结合剂是一种重要的治疗方法;然而,不遵医嘱仍然是一个重大问题。本研究旨在调查患者对药物的信念是否可以预测他们故意不遵守使用磷酸盐结合剂的医嘱。
这是一项针对 ESRD 患者(n=76)的横断面研究。采用两种方法测量不遵医嘱情况:(1)自我报告的用药依从性问卷(MAQ)和(2)3 个月平均血清磷酸盐水平。使用“药物信念问卷”评估患者对磷酸盐药物的一般和特定信念。
11 名(76 名患者的 14.5%)患者报告故意不遵守使用磷酸盐结合剂的医嘱。患者认为磷酸盐结合剂不太必要的信念与故意自我报告的不遵医嘱显著相关。此外,对磷酸盐结合剂更担心的患者其血清磷酸盐水平更高。
评估患者对药物的信念是其故意不遵守使用磷酸盐结合剂医嘱的可靠指标。这些发现可能有助于确定提高患者对磷酸盐结合剂治疗依从性的方法。